These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3766288)

  • 1. p-Nitrosophenetole: a reactive intermediate of phenacetin that binds to protein.
    Hinson JA; Mays JB
    Adv Exp Med Biol; 1986; 197():691-6. PubMed ID: 3766288
    [No Abstract]   [Full Text] [Related]  

  • 2. Covalent binding of the phenacetin metabolite p-nitrosophenetole to protein.
    Hinson JA; Mays JB
    J Pharmacol Exp Ther; 1986 Jul; 238(1):106-12. PubMed ID: 3723393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic activation of phenacetin and phenetidine by several forms of cytochrome P-450 purified from liver microsomes of rats and hamsters.
    Nohmi T; Mizokami K; Kawano S; Fukuhara M; Ishidate M
    Jpn J Cancer Res; 1987 Feb; 78(2):153-61. PubMed ID: 3104258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The binding of radioactive label from labelled phenacetin and related compounds to rat tissues in vivo and to nucleic acids and bovine plasma albumin in vitro.
    Nery R
    Biochem J; 1971 Apr; 122(3):311-5. PubMed ID: 5118104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of phenacetin-induced methemoglobinemia by diethyldithiocarbamate and carbon disulfide and its relation to phenacetin metabolism in mice.
    Nakayama N; Masuda Y
    J Pharmacobiodyn; 1985 Oct; 8(10):868-76. PubMed ID: 3005542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenicity of N-hydroxy-2-acetylaminofluorene and N-hydroxy-phenacetin and their respective deacetylated metabolites in nitroreductase deficient Salmonella TA98FR and TA100FR.
    Wirth PJ; Alewood P; Calder I; Thorgeirsson SS
    Carcinogenesis; 1982; 3(2):167-70. PubMed ID: 6896016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaction of mutagenic phenacetin metabolites with glutathione and DNA. Possible implications for toxicity.
    Mulder GJ; Kadlubar FF; Mays JB; Hinson JA
    Mol Pharmacol; 1984 Sep; 26(2):342-7. PubMed ID: 6482879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of N-hydroxyphenetidine in phenacetin-induced hemolytic anemia.
    Jensen CB; Jollow DJ
    Toxicol Appl Pharmacol; 1991 Oct; 111(1):1-12. PubMed ID: 1949026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism of N-hydroxyphenacetin in vitro and in vivo.
    Fischbach T; Lenk W
    Xenobiotica; 1985 Nov; 15(11):915-27. PubMed ID: 4082632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of barbiturates to hepatic microsomes of the rat.
    Sitar DS; Mannering GJ
    Biochem Pharmacol; 1977 May; 26(10):988-91. PubMed ID: 861047
    [No Abstract]   [Full Text] [Related]  

  • 11. Species-specific activation of phenacetin into bacterial mutagens by hamster liver enzymes and identification of N-hydroxyphenacetin O-glucuronide as a promutagen in the urine.
    Camus AM; Friesen M; Croisy A; Bartsch H
    Cancer Res; 1982 Aug; 42(8):3201-8. PubMed ID: 7046920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolism of phenacetin and p-phenetidine in the kidney].
    Uehleke H; Schnitger F
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):319. PubMed ID: 4390701
    [No Abstract]   [Full Text] [Related]  

  • 13. Species difference in the metabolic activation of phenacetin by rat and hamster liver microsomes.
    Nohmi T; Yoshikawa K; Nakadate M; Ishidate M
    Biochem Biophys Res Commun; 1983 Feb; 110(3):746-52. PubMed ID: 6404262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship for deacetylation of a homologous series of phenacetin analogs and their N-hydroxy derivatives.
    Estus GS; Mieyal JJ
    Drug Metab Dispos; 1983; 11(5):471-6. PubMed ID: 6138233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible binding of DOPA and dopamine metabolites to protein by rat liver microsomes.
    Scheulen M; Wollenberg P; Bolt HM; Kappus H; Remmer H
    Biochem Biophys Res Commun; 1975 Oct; 66(4):1396-400. PubMed ID: 1191300
    [No Abstract]   [Full Text] [Related]  

  • 16. Irreversible protein binding of metabolites of ethynylestradiol in vivo and in vitro.
    Kappus H; Bolt HM; Remmer H
    Steroids; 1973 Aug; 22(2):203-25. PubMed ID: 4147486
    [No Abstract]   [Full Text] [Related]  

  • 17. Generation of reactive metabolites of N-hydroxy-phenacetin by glucoronidation and sulfation.
    Mulder GJ; Hinson JA; Gillette JR
    Biochem Pharmacol; 1977 Feb; 26(3):189-96. PubMed ID: 402923
    [No Abstract]   [Full Text] [Related]  

  • 18. Formation of chemically reactive metabolites of phenacetin and acetaminophen.
    Gillette JR; Nelson SD; Mulder GJ; Jollow DJ; Mitchell JR; Pohl LR; Hinson JA
    Adv Exp Med Biol; 1981; 136 Pt B():931-50. PubMed ID: 6953755
    [No Abstract]   [Full Text] [Related]  

  • 19. Formation of 4-ethoxy-4'-nitrosodiphenylamine in the reaction of the phenacetin metabolite 4-nitrosophenetol with glutathione.
    Klehr H; Eyer P; Schäfer W
    Biol Chem Hoppe Seyler; 1987 Aug; 368(8):895-902. PubMed ID: 3663328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic activation by human arylacetamide deacetylase, CYP2E1, and CYP1A2 causes phenacetin-induced methemoglobinemia.
    Kobayashi Y; Fukami T; Higuchi R; Nakajima M; Yokoi T
    Biochem Pharmacol; 2012 Nov; 84(9):1196-206. PubMed ID: 22940574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.